Works matching IS 10837159 AND DT 2008 AND VI 13 AND IP 6

Results: 20

Symptom management and supportive care. Treating anemia of cancer with every-4-week darbepoetin alfa: final efficacy and safety results from a phase II, randomized, double-blind, placebo-controlled study.

Published in:

2008

By:

Gordon D;
Nichols G;
Ben-Jacob A;
Tomita D;
Lillie T;
Miller C

Publication type:

Journal Article

Response to 'Commentary: lung cancer screening--progress or peril'.

Published in:

2008

By:

McMahon PM;
Gazelle GS

Publication type:

Journal Article

Symptom management and supportive care. Managing premedications and the risk for reactions to infusional monoclonal antibody therapy.

Published in:

2008

By:

Chung CH

Publication type:

Journal Article

Use of H2 15O-PET and DCE-MRI to measure tumor blood flow.

Published in:

2008

By:

De Langen AJ;
Van Den Boogaart VEM;
Marcus JT;
Lubberink M

Publication type:

Journal Article

18F-fluorodeoxyglucose positron emission tomography for monitoring response to sorafenib treatment in patients with hepatocellular carcinoma.

Published in:

2008

By:

Siemerink EJM;
Mulder NH;
Brouwers AH;
Hospers GAP;
Boss DS;
Olmos RV;
Sinaasappel M;
Beijnen JH;
Schellens JHM

Publication type:

Journal Article

ERRATUM.

Published in:: 2008
Publication type:: Correction Notice

18F-Fluorodeoxyglucose Positron Emission Tomography for Monitoring Response to Sorafenib Treatment in Patients with Hepatocellular Carcinoma.

Published in:

2008

By:

Siemerink, Ester J. M.;
Mulder, Nanno H.;
Brouwers, Adrienne H.;
Hospers, Geke A. P.

Publication type:

Letter

Response to "Commentary: Lung Cancer Screening--Progress or Peril.".

Published in:

2008

By:

Mcmahon, Pamela M.;
Gazellea, G. Scott

Publication type:

Letter

Managing Premedications and the Risk for Reactions to Infusional Monoclonal Antibody Therapy.

Published in:

Oncologist, 2008, v. 13, n. 6, p. 725, doi. 10.1634/theoncologist.2008-0012

By:

Chung, Christine H.

Publication type:

Article

Treating Anemia of Cancer with Every-4-Week Darbepoetin Alfa: Final Efficacy and Safety Results from a Phase II, Randomized, Double-Blind, Placebo-Controlled Study.

Published in:

Oncologist, 2008, v. 13, n. 6, p. 715, doi. 10.1634/theoncologist.2007-0241

By:

Gordon, David;
Nichols, Gwen;
Ben-Jacob, Ali;
Tomita, Dianne;
Lillie, Tom;
Miller, Carole

Publication type:

Article

FDA Drug Approval Summary: Nelarabine (Arranon) for the Treatment of T-Cell Lymphoblastic Leukemia/Lymphoma.

Published in:

Oncologist, 2008, v. 13, n. 6, p. 709, doi. 10.1634/theoncologist.2006-0017

By:

Cohen, Martin H.;
Johnson, John R.;
Justice, Robert;
Pazdur, Richard

Publication type:

Article

Modern Radiotherapy as Part of Combined Modality Treatment in Locally Advanced Non-Small Cell Lung Cancer: Present Status and Future Prospects.

Published in:

Oncologist, 2008, v. 13, n. 6, p. 700, doi. 10.1634/theoncologist.2007-0196

By:

Van Meerbeeck, Jan P.;
Meersschout, Sabine;
De Pauw, Rebecca;
Madani, Indira;
De Neve, Wilfried

Publication type:

Article

Pediatric Central Nervous System Germ Cell Tumors: A Review.

Published in:

Oncologist, 2008, v. 13, n. 6, p. 690, doi. 10.1634/theoncologist.2008-0037

By:

Echevarría, Maria E.;
Fangusaro, Jason;
Goldman, Stewart

Publication type:

Article

Characteristics and Outcome of Pediatric Patients Enrolled in Phase I Oncology Trials.

Published in:

Oncologist, 2008, v. 13, n. 6, p. 679, doi. 10.1634/theoncologist.2008-0046

By:

Kim, Aerang;
Fox, Elizabeth;
Warren, Katherine;
Blaney, Susan M.;
Berg, Stacey L.;
Adamson, Peter C.;
Libucha, Madeleine;
Byrley, Elena;
Balis, Frank M.;
Widemann, Brigitte C.

Publication type:

Article

Pediatric Nonrhabdomyosarcoma Soft Tissue Sarcomas.

Published in:

Oncologist, 2008, v. 13, n. 6, p. 668, doi. 10.1634/theoncologist.2007-0182

By:

Spunt, Sheri L.;
Skapek, Stephen X.;
Coffin, Cheryl M.

Publication type:

Article

Radiolabeled and Native Antibodies and the Prospect of Cure of Follicular Lymphoma.

Published in:

Oncologist, 2008, v. 13, n. 6, p. 657, doi. 10.1634/theoncologist.2008-0020

By:

Buchegger, Franz;
Press, Oliver W.;
Delaloye, Angelika Bischof;
Ketterer, Nicolas

Publication type:

Article

Commentary: Let the Tail Wag the Dog: The Case for Radioimmunotherapy of Low-Grade Follicular Lymphoma.

Published in:

Oncologist, 2008, v. 13, n. 6, p. 655, doi. 10.1634/theoncologist.2008-0113

By:

Plastaras, John P.;
Glatstein, Eli;
Schuster, Stephen J.

Publication type:

Article

Is There an Entity of Chemically Induced BCR-ABL--Positive Chronic Myelogenous Leukemia?

Published in:

Oncologist, 2008, v. 13, n. 6, p. 645, doi. 10.1634/theoncologist.2008-0057

By:

Lichtman, Marshall A.

Publication type:

Article

Use of H215O-PET and DCE-MRI to Measure Tumor Blood Flow.

Published in:

Oncologist, 2008, v. 13, n. 6, p. 631, doi. 10.1634/theoncologist.2007-0235

By:

De Langen, Adrianus J.;
Van Den Boogaart, Vivian E. M.;
Marcus, J. Tim;
Lubberink, Mark

Publication type:

Article

Trastuzumab in the Adjuvant Treatment of Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Published in:

Oncologist, 2008, v. 13, n. 6, p. 620, doi. 10.1634/theoncologist.2008-0001

By:

Dahabreh, Issa J.;
Linardo, Helen;
Siannis, Fotios;
Fountzilas, George;
Murray, Samuel

Publication type:

Article

Works matching IS 10837159 AND DT 2008 AND VI 13 AND IP 6

Symptom management and supportive care. Treating anemia of cancer with every-4-week darbepoetin alfa: final efficacy and safety results from a phase II, randomized, double-blind, placebo-controlled study.

Response to 'Commentary: lung cancer screening--progress or peril'.

Symptom management and supportive care. Managing premedications and the risk for reactions to infusional monoclonal antibody therapy.

Use of H2 15O-PET and DCE-MRI to measure tumor blood flow.

18F-fluorodeoxyglucose positron emission tomography for monitoring response to sorafenib treatment in patients with hepatocellular carcinoma.

ERRATUM.

<sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography for Monitoring Response to Sorafenib Treatment in Patients with Hepatocellular Carcinoma.

Response to "Commentary: Lung Cancer Screening--Progress or Peril.".

Managing Premedications and the Risk for Reactions to Infusional Monoclonal Antibody Therapy.

Treating Anemia of Cancer with Every-4-Week Darbepoetin Alfa: Final Efficacy and Safety Results from a Phase II, Randomized, Double-Blind, Placebo-Controlled Study.

FDA Drug Approval Summary: Nelarabine (Arranon) for the Treatment of T-Cell Lymphoblastic Leukemia/Lymphoma.

Modern Radiotherapy as Part of Combined Modality Treatment in Locally Advanced Non-Small Cell Lung Cancer: Present Status and Future Prospects.

Pediatric Central Nervous System Germ Cell Tumors: A Review.

Characteristics and Outcome of Pediatric Patients Enrolled in Phase I Oncology Trials.

Pediatric Nonrhabdomyosarcoma Soft Tissue Sarcomas.

Radiolabeled and Native Antibodies and the Prospect of Cure of Follicular Lymphoma.

Commentary: Let the Tail Wag the Dog: The Case for Radioimmunotherapy of Low-Grade Follicular Lymphoma.

Is There an Entity of Chemically Induced BCR-ABL--Positive Chronic Myelogenous Leukemia?

Use of H<sub>2</sub><sup>15</sup>O-PET and DCE-MRI to Measure Tumor Blood Flow.

Trastuzumab in the Adjuvant Treatment of Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.